国际医药卫生导报2010，Vol.16Issue(13)：1569-1571,3.DOI:10.3760/cma.j.issn.1007-1245.2010.13.012
注射用血凝酶治疗拔牙术后顽固性出血的临床研究
Hemocoagulase atrox for injection in the treatment of post-extraction refractory bleeding
匡世军 1郑有华 1张志光 1苏凯1
作者信息
- 1. 510055,广州,中山大学光华口腔医学院附属口腔医院口腔颌面外科
- 折叠
摘要
Abstract
Objective To assess the efficacy of hemocoagulase atrox for injection in the treatment of post-extraction refractory bleeding. Methods 32 patients aged 21 to 72 (11 males and 21 females, mean age 42 years) who had been diagnosed as post-extraction refractory bleeding during July 2006 to July 2009 in Sun Yat-Sen university school of stomatology were randomly to receive 2U of hemocoagulase atrox for injection (16 patients, study group), or 0.5 g of etamsvlatum (16 patients, control group). The local hemostatic status was observed and the hemostatic effect was compared between the two groups with chi square test.Results There was a statistical significance between the study group and the control group in the effective rate (93.8% vs. 56.3%; x2= 6,P<0.05). Conclusions Hemocoagulase atrox for injection has a better hemostatic effect on post-extraction refractory bleeding.关键词
注射用血凝酶/拔牙/术后出血Key words
Hemocoagulase atrox for injection/Tooth extraction/Postoperative bleeding引用本文复制引用
匡世军,郑有华,张志光,苏凯..注射用血凝酶治疗拔牙术后顽固性出血的临床研究[J].国际医药卫生导报,2010,16(13):1569-1571,3.
